Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. - Wikidata - awgldk - TriplyDB

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

http://www.wikidata.org/entity/Q41773542

about

Immunological Evasion in Glioblastoma Immunotherapy for cancer in the central nervous system: Current and future directions Overview of current immunotherapeutic strategies for glioma Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites Therapeutic cancer vaccines: past, present, and future Reciprocal relationship between myeloid-derived suppressor cells and T cells A role for G-CSF and GM-CSF in nonmyeloid cancers Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease Coordinated regulation of myeloid cells by tumours Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.Strategies for improving the reporting of human immunophenotypes by flow cytometry.Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Identification of myeloid derived suppressor cells in the peripheral blood of tumor bearing dogs.Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses.Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.Cellular-based immunotherapies for patients with glioblastoma multiforme.Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.Recent developments on immunotherapy for brain cancer.PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Correlation between circulating myeloid-derived suppressor cells and Th17 cells in esophageal cancer.IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients.The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.

P2860

Q26746612-311D1947-E7F2-4AB3-B212-2F0F305653BE Q26750765-83F4178C-9683-43E0-AD8B-381FF18EC514 Q26776345-810EB46E-611D-4DED-A35B-4E34B8E3B787 Q26798402-97598E6B-1E43-4FCC-BD0A-6C7D0CB528EA Q26863283-9B7874F5-6E8E-4E1C-BD54-E1A754CBEAB0 Q27000664-12BA4807-BBCC-4E1B-B88B-5F223097AC60 Q27002515-8790D9C5-102A-48F9-AF5E-D9F848ADD064 Q27014189-1CA73FEC-DC16-40BD-AA2F-37A0B2B713D2 Q27014829-4AF4A7A2-74F6-4763-A978-EB16521DB23D Q28087485-75D8F2E5-946F-4B25-BA60-76F981171415 Q28391826-25D2E629-1A22-45A2-ABE9-CAE5E9C4F6BC Q28395157-5199CF3F-6E2F-43DC-A772-DA3C89832AC2 Q33578030-42708AED-1D6B-42EC-8330-E6C6D50815A9 Q33606132-E5AC4FEF-3D1A-46D4-B1AA-60ACF5735997 Q33822690-BAE26754-0946-45CA-8025-12E7812829CC Q33888808-8A2B3126-0EA3-4AE9-9B0C-90CD94114B9A Q34276759-154D3120-96DA-4D17-8B42-16B12A97F1CD Q34315871-665FDE39-373A-44BA-9923-C2CCBC3545CB Q34461732-0328A79D-CD6C-4726-881D-718416BFDE08 Q34576982-362B2E6C-F4C6-4B15-B407-0F1372558DA5 Q34600087-E5F21697-882A-43B8-9114-1BD6D3059B95 Q34810257-BAAC965D-80AF-4545-AE66-821913D7F4BF Q35071370-D1728A04-5B7B-4D0E-93BD-B3B573DEE113 Q35227405-930F3B39-91EC-44E5-98B6-183939326BC0 Q35236790-0F1C0F3E-60D8-4E41-A9DD-1A2F7183B48F Q35271470-87B0DF06-E736-4BF1-9652-5979E46A27FB Q35553327-FADCC9E5-D567-44B1-91A6-8E5906835BB4 Q35610772-2B1088A2-F8B6-4A61-9AD9-D483BFF80621 Q35613040-62E3691D-CB17-43F0-A9B9-1500D41D5190 Q35726496-4C54382D-8F47-41E7-A37A-A62A66768CD6 Q35821404-740F70FA-301E-403F-8884-B69AEAC87A27 Q35863183-36CD3F92-8F09-4374-9DF3-16737CFF34D8 Q35992355-509EAB35-6CF3-4EAC-94B4-E10F8C256254 Q36086507-384260AE-58DD-4F3C-9AD2-08CB0C2652B5 Q36316728-A38BA8F7-4542-48D7-940F-3B98D220B0B6 Q36405905-67D01512-2C93-4BF4-8DC2-0056FDD2FE74 Q36456474-2769F85C-5273-44C2-BB8B-9B9FBDEF7C39 Q36493820-DB2D508C-5C45-4495-A084-72AF7226A9C0 Q36584178-1EA4861D-8ADA-44D5-8384-2CFDB8C2A3F3 Q36600997-C2B6E358-5A37-4FEF-B594-3DF0FFAE2192

P2860

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

http://www.wikidata.org/entity/Q41773542

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Myeloid-derived suppressor cel ...... newly diagnosed glioblastoma.

@en

type

label

Myeloid-derived suppressor cel ...... newly diagnosed glioblastoma.

@en

prefLabel

Myeloid-derived suppressor cel ...... newly diagnosed glioblastoma.

@en

P1433

Q41773542-54E0F50F-C025-4A33-846E-86CC8221AFDF

P1476

Q41773542-C79D7C11-1BB2-4357-BDEA-335727A90E40

P2093

Q41773542-3067CFF4-1868-4653-AAA8-C9956696EF0A

Q41773542-4D5F3C3B-3018-4BC9-80F4-7BAFF1372AEB

Q41773542-798578A1-CBA4-4275-B330-A772E0BB0A03

Q41773542-8F61E9C5-8114-4FA2-A187-C17B56D184C3

Q41773542-97A47011-C488-4496-8CD2-3C94EB0D0E52

Q41773542-AA344B21-5FA7-4D86-A7FA-F75E028E28AE

Q41773542-DE3084F6-9A1C-48F9-8387-FBAF7117418D

Q41773542-E1EA93F5-9ED1-48E5-8DE7-A744CBF8E989

Q41773542-FDA56153-EAFB-44E3-8E44-1C66B7BDF3EF

P2860

Q41773542-07B85605-9451-47C8-AD1B-0527C72B6A47

Q41773542-12C39D54-5258-4801-8153-3C767864C892

Q41773542-1CC7234D-8867-4780-A2FB-DA609EE4DE60

Q41773542-28D3B053-0FCB-4361-AB2A-3476D788D2C4

Q41773542-4DC34F2C-18A5-4E93-9DD2-69E34B2E9BC9

Q41773542-4F81C433-64D0-40A0-9605-B2527CEAB0A5

Q41773542-5BC9B367-1DDB-4D37-935A-94065FDC5EDE

Q41773542-604F943E-401C-4C58-B4BD-FE28CA733E63

Q41773542-61222A91-A8EE-4B23-9666-9CD1374BC21B

Q41773542-6F729A39-0155-40D0-901A-2EAC773714E7

P304

Q41773542-3E0D4D0C-8BEC-43F6-B5D6-AAD9935248EB

P31

Q41773542-BC6843FD-206C-4320-A7B4-9CDF0A89364A

P356

Q41773542-D1E123AA-CB09-4731-82B8-B41E71EE9292

P433

Q41773542-A000B7BB-C33A-4A0E-8212-943CD0F049CD

P478

Q41773542-3B906296-6CDD-4AB6-A55E-31A43EBA3FC8

P577

Q41773542-C41F3427-B1C4-4CAC-BEEF-B4E65EFF4B54

P5875

Q41773542-6E07C981-1DCE-4A63-9586-96E523EFBB53

P698

Q41773542-1E1D5DF0-6814-4D07-B0C4-EA4520E0730E

P932

Q41773542-14952653-D1E3-4FB3-BD94-DC4B9BEDE9CB

P356

P1433

P1476

Myeloid-derived suppressor cel ...... newly diagnosed glioblastoma.

@en

P2093

Baisakhi Raychaudhuri

http://www.w3.org/2001/XMLSchema#string

Brian Rini

http://www.w3.org/2001/XMLSchema#string

Ernest C Borden

http://www.w3.org/2001/XMLSchema#string

James Finke

http://www.w3.org/2001/XMLSchema#string

Jennifer Ko

http://www.w3.org/2001/XMLSchema#string

Joanna Ireland

http://www.w3.org/2001/XMLSchema#string

Jorge Garcia

http://www.w3.org/2001/XMLSchema#string

Michael A Vogelbaum

http://www.w3.org/2001/XMLSchema#string

Patricia Rayman

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells as regulators of the immune system

Regulation of enzymes of the urea cycle and arginine metabolism

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

Tumor-induced immune dysfunctions caused by myeloid suppressor cells.

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.

Myeloid-derived suppressor cells.

P304

591-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR042

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51187149

http://www.w3.org/2001/XMLSchema#string

P698

21636707

http://www.w3.org/2001/XMLSchema#string

P932

3107102

http://www.w3.org/2001/XMLSchema#string